Global Cost-effectiveness of Cataract Surgery

Ophthalmology

Volumn 114, Issue 9, 2007, Pages 1670-1678

  Lansingh, Van C ^a   Carter, Marissa J ^b   Martens, Marion ^a  

^a FUNDACIÓN VISIÓN   (Paraguay)

^b Strategic Solutions Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CATARACT EXTRACTION; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DEFIBRILLATOR; DEVELOPING COUNTRY; HEALTH CARE COST; HIP ARTHROPLASTY; HUMAN; KNEE ARTHROPLASTY; META ANALYSIS; PRIORITY JOURNAL; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW;

CATARACT; CATARACT EXTRACTION; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; HEALTH CARE COSTS; HEALTH SERVICES RESEARCH; HUMANS; MODELS, ECONOMETRIC; QUALITY-ADJUSTED LIFE YEARS; UNITED STATES; WORLD HEALTH;

EID: 34548215180     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2006.12.013     Document Type: Article

References (77)

1. Thylefors B., Negrel A.D., Pararajasegaram R., and Dadzie K.Y. Global data on blindness. Bull World Health Organ 73 (1995) 115-121
2. Resnikoff S., Pascolini D., Etya'ale D., et al. Global data on visual impairment in the year 2002. Bull World Health Organ 82 (2004) 844-851
3. Pizzarello L., Abiose A., Ffytche T., et al. VISION 2020. The right to sight: a global initiative to eliminate avoidable blindness. Arch Ophthalmol 122 (2004) 615-620
4. Frick K.D., and Foster A. The magnitude and cost of global blindness: an increasing problem that can be alleviated. Am J Ophthalmol 135 (2003) 471-476
5. World Development Report 1993. Investing in Health (1993), Oxford University Press, New York 23. http://www.dcp2.0rg/file/62/World%20Development%20Report%201993.pdf Available at: http://www.dcp2.0rg/file/62/World%20Development%20Report%201993.pdf. Accessed December 1, 2006
6. Brown M.M., and Brown G.C. How to interpret a healthcare economic analysis. Curr Opin Ophthalmol 16 (2005) 191-194
7. Brown G.C., Brown M.M., and Sharma S. Health care economic analysis. Retina 24 (2004) 139-146
8. Redelmeier D.A., and Detsky A.S. A clinician's guide to utility measurement. Prim Care 22 (1995) 271-280
9. Feeny D.H., and Torrance D.W. Incorporating utility-based quality-of-life assessment measures in clinical trials: two examples. Med Care 27 suppl (1989) S190-S204
10. Wakker P., and Stiggelbout A. Explaining distortions in utility elicitation through the rank-dependent model for risky choices. Med Decis Making 15 (1995) 180-186
11. Richardson J. Cost utility analysis: what should be measured?. Soc Sci Med 39 (1994) 7-21
12. Brown G.C. Vision and quality-of-life. Trans Am Ophthalmol Soc 97 (1999) 473-511
13. Kassirer J.P. Incorporating patients' preferences into medical decisions. New Engl J Med 330 (1994) 1895-1896
14. Revicki D.A., and Kaplan D.M. Relationship between psychometric and utility-based approaches to the measurement of health-related quality of life. Qual Life Res 2 (1993) 477-487
15. Gafni A. The standard gamble method: what is being measured and how it is interpreted. Health Serv Res 29 (1994) 207-224
16. Drummond M.F., O'Brien B., Stoddart C.L., et al. Methods for the Economic Evaluation of Health Care Programmes. 2nd ed. (1997), Oxford University Press, Oxford, UK 139-204
17. Von Neumann J., and Morgenstern O. Theory of Games and Economic Behavior (1944), Princeton University Press, Princeton, NJ 15-29
18. Groot W. Adaptation and scale of reference bias in self-assessments of quality of life. J Health Econ 19 (2000) 403-420
19. Gold M.R., Patrick D.L., and Torrance G.W. Identifying and valuing outcomes. In: Gold M.R., Siegel J.E., Russell L.B., and Weinstein M.C. (Eds). Cost-Effectiveness in Health and Medicine (1996), Oxford University Press, New York 82-134
20. Cutler D.M., and Richardson E. Measuring the health of the United States population (1997), Brookings Pap Econ Act Microecon 217-271
21. Cutler D., and Richardson E. The value of health: 1970-1990. Am Econ Rev 88 (1998) 97-100
22. Steinberg E.P., Tielsch J.M., Schein O.D., et al. The VF-14: an index of functional impairment in patients with cataract. Arch Ophthalmol 112 (1994) 630-638
23. Brown M.M., Brown G.C., Sharma S., and Landy J. Health care economic analyses and value-based medicine. Surv Ophthalmol 48 (2003) 204-223
24. Mangione C.M., Berry S., Spritzer K., et al. Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons. Arch Ophthalmol 116 (1998) 227-233
25. Kobelt G., Lundström M., and Stenevi U. Cost-effectiveness of cataract surgery: method to assess cost-effectiveness using registry data. J Cataract Refract Surg 28 (2002) 1742-1749
26. Misajon R., Hawthorne G., Richardson J., et al. Vision and quality of life: the development of a utility measure. Invest Ophthalmol Vis Sci 46 (2005) 4007-4015
27. Hutubessy R.C., Baltussen R.M., Tan Torres-Edejer T.T., and Evans D.B. Generalised cost-effectiveness analysis: an aid to decision making in health. Appl Health Econ Health Policy 1 (2002) 89-95
28. Murray C.J., Evans C.B., Acharaya A., and Baltussen R.M. Development of WHO guidelines on generalized cost-effectiveness analysis. Health Econ 9 (2000) 235-251
29. Evans D.B., Tan-Torres Edejer T., Adam T., Lim S.S., and WHO Choosing Interventions That Are Cost Effective (CHOICE) Millennium Development Goals Team. Methods to assess the costs and health effects of interventions for improving health in developing countries. BMJ 331 (2005) 1137-1140
30. Busbee B.G., Brown M.M., Brown G.C., and Sharma S. Incremental cost-effectiveness of initial cataract surgery. Ophthalmology 109 (2002) 606-612
31. Busbee B.G., Brown M.M., Brown G.C., and Sharma S. Cost-utility analysis of cataract surgery in the second eye. Ophthalmology 110 (2003) 2310-2317
32. Räsänen P., Krootila K., Sintonen H., et al. Cost-utility of routine cataract surgery. Health Qual Life Outcomes 4 (2006) 74
33. Baltussen R., Sylla M., and Mariotti S.P. Cost-effectiveness analysis of cataract surgery: a global and regional analysis. Bull World Health Organ 82 (2004) 338-345
34. Asimakis P., Coster D.J., and Lewis D.J. Cost effectiveness of cataract surgery. Aust N Z J Ophthalmol 24 (1996) 319-325
35. Fan Y.P., Boldy D., and Bowen D. Comparing patient satisfaction, outcomes and costs between cataract day surgery and inpatient surgery for elderly people. Aus Health Rev 20 (1997) 27-39
36. Saad Filho R., Saad F.G., and Freitas L.L. Cost of phacoemulsification in the national campaigning of elective cataract surgery in Itápolis, SP, Brazil [in Portuguese]. Arq Bras Oftalmol 68 (2005) 55-59
37. Chen S.H., and Arshinoff S.A. A cost-analysis of unilateral vs. simultaneous bilateral cataract surgery in Canada. Clin Surg Ophthalmol 23 (2005) 324-332
38. Nghiem-Buffet M.H., de Pouvourville G., Renard G., et al. Cost of managing cataracts: evaluation of traditional hospitalization and ambulatory surgery [in French]. Presse Med 30 (2001) 1924-1926
39. Landwehr I., Tehrani M., Dick H.B., and Krummenauer F. Cost effectiveness evaluation of cataract patient care in respect of monofocal intraocular lenses from the perspective of German statutory health insurance [in German]. Klin Monatsbl Augenheilkd 220 (2003) 532-539
40. Muralikrishnan R., Venkatesh R., Prajna N.V., and Frick K.D. Economic cost of cataract surgery procedures in an established eye care centre in southern India. Ophthalmic Epidemiol 11 (2004) 369-380
41. Gogate P.M., Deshpande M., and Wormald R.P. Is manual small incision cataract surgery affordable in the developing countries?. A cost comparison with extracapsular cataract extraction. Br J Ophthalmol 87 (2003) 843-846
42. Loo C.Y., Kandiah M., Arumugam G., et al. Cost efficiency and cost effectiveness of cataract surgery at the Malaysian Ministry of Health Ophthalmic Services. Int Ophthalmol 25 (2004) 81-87
43. Rizal A.M., Aljunid S.M., Normalina M., et al. Cost analysis of cataract surgery with intraocular lens implantation: a single blind randomised clinical trial comparing extracapsular cataract extraction and phacoemulsification. Med J Malaysia 58 (2003) 380-386
44. Marseille E. Cost-effectiveness of cataract surgery in a public health eye care programme in Nepal. Bull World Health Organ 74 (1996) 319-324
45. Ruit S., Tabin G.C., Nissman S.A., et al. Low-cost high-volume extracapsular cataract extraction with posterior chamber intraocular lens implantation in Nepal. Ophthalmology 106 (1999) 1887-1892
46. Castells X., Alonso J., Castilla M., et al. Outcomes and costs of outpatient and inpatient cataract surgery; a randomised clinical trial. J Clin Epidemiol 54 (2001) 23-29
47. Lundström M., Brege K.G., Florén I., et al. Cataract surgery and effectiveness. 1. Variation in costs between different providers of cataract surgery. Acta Ophthalmol Scand 78 (2000) 335-339
48. Lewallen S., Geneau R., Mahande M., et al. Willingness to pay for cataract surgery in two regions of Tanzania. Br J Ophthalmol 90 (2006) 11-13
49. Cresswell P.A., Allen E.D., Tomkinson J., et al. Cost effectiveness of a single-function treatment center for cataract surgery. J Cataract Refract Surg 22 (1996) 940-946
50. Chung K.C., Walters M.R., Greenfield M.L., and Chernew M.E. Endoscopic versus open carpal tunnel release: a cost-effectiveness analysis. Plast Reconstr Surg 102 (1998) 1089-1099
51. Langfitt J. Cost-effectiveness of anterotemporal lobectomy in medically intractable complex partial epilepsy. Epilepsia 38 (1997) 154-163
52. King Jr. J.T., Sperling M.R., Justice A.C., and O'Connor M.J. A cost-effectiveness analysis of anterior temporal lobectomy for intractable temporal lobe epilepsy. J Neurosurg 87 (1997) 20-28
53. Tureczek I.E., Fandino-Franky J., and Wieser H.G. Comparison of the epilepsy surgery programs in Cartagena, Colombia, and Zurich, Switzerland. Epilepsia 41 suppl 4 (2000) S35-S40
54. Wiebe S., Matijevic S., Eliasziw M., and Derry P.A. Clinically important change in quality of life in epilepsy. J Neurol Neurosurg Psychiatr 73 (2002) 116-120
55. Rorabeck C.H., Bourne R.B., Laupacis A., et al. A double-blind study of 250 cases comparing cemented with cementless total hip arthroplasty: cost-effectiveness and its impact on health-related quality of life. Clin Orthop Relat Res 298 (1994) 156-164
56. Rissanen P., Aro S., Sintonen H., et al. Costs and cost-effectiveness in hip and knee replacements: a prospective study. Int J Technol Assess Health Care 13 (1997) 575-588
57. Keating J.F., Grant A., Masson M., et al. Randomized comparison of reduction and fixation, bipolar hemiarthroplasty, and total hip arthroplasty: treatment of displaced intracapsular hip fractures in healthy older patients. J Bone Joint Surg Am 88 (2006) 249-260
58. Chang R.W., Pellisier J.M., and Hazen G.B. A cost-effectiveness analysis of total hip arthroplasty for osteoarthritis of the hip. JAMA 275 (1996) 858-865
59. Bozic K.J., Katz P., Cisternas M., et al. Hospital resource utilization for primary and revision total hip arthroplasty. J Bone Joint Surg Am 87 (2005) 570-576
60. Donell S.T., Neyret P., Dejour H., and Adeleine P. The effect of age on the quality of life after knee replacement. Knee 5 (1998) 125-128
61. Burns A.W.R., Bourne R.B., Chesworth B.M., et al. Cost effectiveness of revision total knee arthroplasty. Clin Orthop Relat Res 446 (2006) 29-33
62. Thiam M., Fall P.D., Gning S.B., et al. Cardiac pacing in West Africa: feasibility, problems, and perspectives [in French]. Ann Cardiol Angeiol 52 (2003) 212-214 (Paris)
63. Lopez-Jimenez F., Goldman L., Orav E.J., et al. Health values before and after pacemaker implantation. Am Heart J 144 (2002) 687-692
64. Sanders G.D., Hlatky M.A., and Owens D.K. Cost-effectiveness of implantable cardioverter-defibrillators. New Engl J Med 353 (2005) 1471-1480
65. Chan P.S., Stein K., Chow T., et al. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population. J Am Coll Cardiol 48 (2006) 112-121
66. Lundström M., and Wendel E. Duration of self assessed benefit of cataract extraction: a long term study. Br J Ophthalmol 89 (2005) 1017-1020
67. Norregaard J.C., Bernth-Petersen P., Alonso J., et al. Variation in indications for cataract surgery in the United States, Denmark, Canada, and Spain: results from the International Cataract Surgery Outcomes Study. Br J Ophthalmol 82 (1998) 1107-1111
68. Brown M.M., Brown G.C., Sharma S., et al. Quality of life associated with unilateral and bilateral good vision. Ophthalmology 108 (2001) 643-647
69. Rosen P.N., Kaplan R.M., and David K. Measuring outcomes of cataract surgery using the Quality of Well-Being Scale and VF-14 Visual Function Index. J Cataract Refract Surg 31 (2005) 369-378
70. Lee J.E., Fos P.J., Zuniga M.A., et al. Assessing health-related quality of life in cataract patients: the relationship between utility and health-related quality of life measurement. Qual Life Res 9 (2001) 1127-1135
71. Singh A.J., Garner P., and Floyd K. Cost-effectiveness of public-funded options for cataract surgery in Mysore, India. Lancet 355 (2000) 180-184
72. Lundström M., Roos P., Brege K.G., et al. Cataract surgery and effectiveness 2. An index approach for the measurement of output and efficiency of cataract surgery at different surgery departments. Acta Ophthalmol Scand 79 (2001) 147-153
73. Malmquist S. Index numbers and indifferent surfaces. Trab Estat 4 (1953) 209-242
74. Laupacis A., Feeny D., Detsky A.S., and Tugwell P.X. How attractive does a new technology have to be to warrant adoption and utilization?. Tentative guidelines for using clinical and economic evaluations. CMAJ 146 (1992) 473-481
75. Heudebert G.R., Centor R.M., Klapow J.C., et al. What is heartburn worth?. A cost-utility analysis of management strategies. J Gen Intern Med 15 (2000) 175-182
76. Smith A.F., and Brown G.C. Understanding cost-effectiveness: a detailed review. Br J Ophthalmol 84 (2000) 794-798
77. Investing in Health Research and Development: Report of the Ad Hoc Committee in Health Research Relating to Future Intervention Options (1996), World Health Organization, Geneva 8. http://www.who.int/tdr/publications/publications/investing_report.htm TDR/Gen/96.1. Available at: http://www.who.int/tdr/publications/publications/investing_report.htm. Accessed December 1, 2006